PTO WILL NOT ADD WAXMAN/HATCH TIME TO GATT 20-YEAR PATENT TERMS; DECISION DOES NOT AFFECT CAPOTEN, ZANTAC BUT WILL REDUCE NUMBER OF EXTENDED PATENTS
Executive Summary
Pharmaceutical patents that were in force on June 8 will not have Waxman/Hatch extensions added on to the new 20-year terms set by the Uruguay Round Agreements Act, the Patent & Trademark Office ruled in a Federal Register notice published June 7.